Skip to main content

Loar Holdings Inc

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

LOAR$75.30+3.2%Stored close · as of Nov 6, 2026

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2024-03-31; filed 2024-05-14.

0000950170-24-059554

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2024-06-30; filed 2024-08-13.

0000950170-24-096339

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 93 previous paragraphs and 116 current paragraphs.

54 unchanged; 24 reworded; 32 added; 14 removed; 1 previous and 6 current paragraphs rearranged.

Tables are not compared: 5 previous and 7 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (32)

Current report

On July 18, 2024, Loar Group entered into the Purchase Agreement with AAI, AAI Parent, and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative of AAI Parent, pursuant to which, Loar Group agreed to purchase from AAI Parent all the issued and outstanding equity interests of AAI in exchange for aggregate cash consideration of approximately $385 million, subject to certain adjustments as set forth in the Purchase Agreement. See Note 14, Subsequent Events, of the Notes to Condensed Consolidated Financial Statements for further information.

Current report

Net sales for the three months ended June 30, 2024 increased $23.0 million, or 31.1%, to $97.0 million as compared to $74.0 million for the three months ended June 30, 2023.

Current report

Other income for the three months ended June 30, 2024, of $2.9 million relates to the reduction in the estimated contingent purchase price for the CAV acquisition.

Current report

Interest expense for the three months ended June 30, 2024 decreased $6.0 million, or 35.8%, to $10.6 million compared to $16.6 million for the three months ended June 30, 2023. This decrease was attributable to the repayment of $284.6 million aggregate principal amount of the Company's debt on May 3, 2024 with a portion of the proceeds from our IPO.

Current report

The effective income tax rate for the three months ended June 30, 2024 was 22.9% compared to 41.2% for the three months ended June 30, 2023. The decrease in the effective tax rate was driven by a decrease in the Company's valuation allowance against its deferred tax asset for disallowed interest carryforward due to the repayment and refinancing of the Company's debt during the second quarter of 2024.

Current report

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Current report

Net sales for the six months ended June 30, 2024 increased $40.6 million, or 27.4%, to $188.9 million as compared to $148.2 million for the six months ended June 30, 2023.

Current report

Cost of sales for the six months ended June 30, 2024 increased $22.2 million or 29.7% to $96.9 million compared to $74.7 million for the six months ended June 30, 2023. Cost of sales and the related percentage of net sales for the six months ended June 30, 2024 and 2023 were as follows (in thousands except for percentages):

Current report

Selling, general and administrative expenses increased by $11.8 million to $50.2 million, or 26.6% as a percentage of net sales, for the six months ended June 30, 2024 from $38.3 million, or 25.9 % as a percentage of net sales, for the six months ended June 30, 2023. Selling, general and administrative expenses and the related percentage of net sales for the six months ended June 30, 2024 and 2023 were as follows (amounts in thousands except for percentages):

Current report

Selling, general and administrative expenses increased by 0.7% as a percentage of net sales for the six months ended June 30, 2024 when compared to the same period in 2023. This was primarily driven by stock-based compensation expense, research and development costs, acquisition and facility integration costs, and infrastructure costs related to being a public company, partially offset by the leveraging of fixed costs.

Current report

Other income for the six months ended June 30, 2024, of $2.9 million relates to the reduction in the estimated contingent purchase price for the CAV acquisition.

Current report

Operating income for the six months ended June 30, 2024, was $43.5 million, or 23.0% as a percentage of net sales, compared to $34.7 million, or 23.4% as a percentage of net sales for the six months ended June 30, 2023. The increase in operating income is due to the factors discussed above.

Current report

Interest expense for the six months ended June 30, 2024 decreased $3.6 million, or 11.3%, to $28.4 million compared to $32.0 million for the six months ended June 30, 2023. This decrease was attributable to the repayment of $284.6 million aggregate principal amount of the Company's debt in May 2024 with a portion of the proceeds from our IPO.

Current report

Net income for the six months ended June 30, 2024 was $9.9 million, or 5.2% as a percentage of net sales, compared to a net loss for the six months ended June 30, 2023 of $6.9 million, or 4.7% as a percentage of net sales. The improvement in results is due to the factors discussed above.

Current report

Net cash provided by operating activities was $17.9 million in the six months ended June 30, 2024 compared to net cash used in operating activities of $0.6 million in the six months ended June 30, 2023. The $18.5 million increase in cash provided by operating activities was primarily driven by an increase in net income of $16.8 million. Changes in certain other working capital accounts drove the remainder of the increase for the six months ended June 30, 2024.

Current report

Net cash provided by financing activities in the six months ended June 30, 2024 of $37.6 million was principally related to proceeds from the Company's IPO of $325.7 million, partially offset by payments on our Credit Agreement of $286.3 million. Net cash provided by financing activities in the six months ended June 30, 2023 of $16.9 million was primarily due to borrowings under the credit Agreement to finance the acquisition of DAC.

Current report

On May 3, 2024, the Company used a portion of the net proceeds from its IPO to repay $284.6 million aggregate principal amount of

Current report

term loans under its Credit Agreement plus accrued interest of $0.3 million. The Company wrote-off $0.8 million in unamortized debt issuance costs and expensed $0.8 million in refinancing costs associated with the amendment of the Credit Agreement during the three and six months ended June 30, 2024.

Current report

At June 30, 2024, there was $252.9 million outstanding under the Credit Agreement, and there remained availability of $100.0 million in Delayed Draw Term Loan Commitments and $50.0 million in Revolving Loans.
Removed paragraphs (14)

Previous report

Net sales for the three months ended March 31, 2024 increased $17.6 million, or 23.7%, to $91.8 million as compared to $74.2 million for the three months ended March 31, 2023.

Previous report

The sales mix toward slightly lower margin OEM in our organic total commercial sales, as well as the impact of the higher OEM sales mix of acquisition sales more than offset the increase in organic sales margins due to volume and pricing. This, along with acquisition integration costs resulted in comparable gross profit percentages of net sales for both periods.

Previous report

Selling, general and administrative expenses for the three months ended March 31, 2024 were $22.9 million compared to $18.8 million for the three months ended March 31, 2023. The increase in expenses was primarily driven by the impact of the acquisitions of DAC and CAV in 2023 as well as acquisition integration costs resulting from the consolidation of manufacturing operations.

Previous report

Interest expense for the three months ended March 31, 2024 increased $2.3 million, or 15.1%, to $17.7 million compared to $15.4 million for the three months ended March 31, 2023. This increase was attributable to interest on additional borrowings associated with the acquisitions of DAC and CAV in 2023 and the continued rising interest rates. Interest rates under our Credit Agreement are subject to variability based on market conditions.

Previous report

Net cash provided by operating activities was $10.8 million in the three months ended March 31, 2024 compared to $3.1 million in the three months ended March 31, 2023. The change in accounts receivable during the three months ended March 31, 2024 provided cash of $3.1 million compared to a use of cash of $5.9 million during the three months ended March 31, 2023. The source of cash for the three months ended March 31, 2024 was primarily attributable to the collection of certain large receivables. The increase in the use of cash of $5.9 million for the three months ended March 31, 2023 was primarily attributable to the increase in sales volume and related timing of cash receipts. We actively manage our accounts receivable, along with the related aging and collection efforts.

Previous report

The change in inventories during the three months ended March 31, 2024 was due to a use of cash of $4.8 million compared to a use of cash of $3.9 million in the comparable prior year period. The increase in the use of cash of $0.9 million was primarily driven by increased purchasing to mitigate the effects of supply chain challenges in support of the anticipated increase in 2024 sales volume.

Previous report

Net cash used in financing activities in the three months ended March 31, 2024 and 2023 was principally related to payments on our Credit Agreement of $1.7 million and $1.3 million, respectively.

Previous report

At March 31, 2024, there was $537.5 million outstanding under the Credit Agreement, and there remained available $47.0 million in Delayed Draw Term Loans Commitment and a $20.0 million revolving line of credit. Outstanding term loans and Delayed Draw Term Loans mature on April 2, 2026. Revolving Loans, if any, mature on April 2, 2025.

Previous report

Borrowings under the term loans, the Delayed Draw Term Loans and the Revolving Line of Credit may be designated as a SOFR loan or base rate loan at the option of the borrower. The interest rate on the SOFR rate loans accrued interest at the SOFR rate plus a margin of 7.25%. The interest rate on the base rate loans accrue interest at the base rate plus a margin of 6.25%. Interest is paid every one, two, three or six months at the option of the Company. The unused portion of the Revolving Line of Credit carries a commitment fee of 0.50%.

Previous report

The Credit Agreement requires the maintenance of a quarterly leverage ratio. There are also certain non-financial covenants in place limiting us from, among other things, incurring other indebtedness, creating any liens on our properties, entering into merger or consolidation transactions, disposing of all or substantially all of our assets and payment of certain dividends and distributions. We were in compliance with all financial and nonfinancial covenants of the Credit Agreement as of March 31, 2024.

Previous report

The Credit Agreement requires mandatory prepayments of the principal amount if there is excess cash flow, as defined, during a calendar year. The Credit Agreement permitted voluntary principal prepayments, in whole or in part, at a premium of 3.0% of the amount prepaid during the first year of the agreement, declining evenly to no premium after October 4, 2021. No voluntary prepayments were made under the Credit Agreement.
Reworded paragraphs (24)

Previous wording

This Quarterly Report on Form 10-Q contains both historical information and, “forward-looking statements”within the meaning of Section 21E of the Securities Exchange Act of 19.4, as amended (the Exchange Act), and 27A of the Securities Act of 1933, as amended. All statements other than statements of historical fact included that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements, including, in particular, the statements about our plans, objectives, strategies and prospects regarding, among other things, our financial condition, results of operations and business. We have identified some of these forward-looking statements with words like “believe,” “may,” “will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate” or “continue” and other words and terms of similar meaning. These forward-looking statements may be contained throughout this Quarterly Report on Form 10-Q. These forward-looking statements are based on current expectations about future events affecting us and are subject to uncertainties and factors relating to, among other things, our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Many factors mentioned in our discussion in this Quarterly Report on Form 10-Q, including the risks outlined under “Risk Factors,” will be important in determining future results. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we do not know whether our expectations will prove correct. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties, including those described under “Risk Factors” in the Quarterly Report on Form 10-Q. Since our actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, we cannot give any assurance that any of the events anticipated by these forward-looking statements will occur or, if any of them does occur, what impact they will have on our business, results of operations and financial condition. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We do not undertake any obligation to update these forward-looking statements or the risk factors contained in this Quarterly Report on Form 10-Q to reflect new information, future events or otherwise, except as may be required under federal securities laws.

Current wording

This Quarterly Report on Form 10-Q contains both historical information and, “forward-looking statements”within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and 27A of the Securities Act of 1933, as amended. All statements other than statements of historical fact included that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements, including, in particular, the statements about our plans, objectives, strategies and prospects regarding, among other things, our financial condition, results of operations and business. We have identified some of these forward-looking statements with words like “believe,” “may,” “will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate” or “continue” and other words and terms of similar meaning. These forward-looking statements may be contained throughout this Quarterly Report on Form 10-Q. These forward-looking statements are based on current expectations about future events affecting us and are subject to uncertainties and factors relating to, among other things, our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Many factors mentioned in our discussion in this Quarterly Report on Form 10-Q, including the risks outlined under “Risk Factors,” will be important in determining future results. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we do not know whether our expectations will prove correct. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties, including those described under “Risk Factors” in the Quarterly Report on Form 10-Q. Since our actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, we cannot give any assurance that any of the events anticipated by these forward-looking statements will occur or, if any of them does occur, what impact they will have on our business, results of operations and financial condition. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We do not undertake any obligation to update these forward-looking statements, or the risk factors contained in this Quarterly Report on Form 10-Q, to reflect new information, future events or otherwise, except as may be required under federal securities laws.

Previous wording

On April 29, 2024, we completed our IPO in which we issued and sold 12.65 million shares of our common stock at an IPO price of $28.00 per share. We received net proceeds from the IPO of $326.1 million after deducting underwriting discounts and offering costs.

Current wording

On April 29, 2024, we completed our IPO in which we issued and sold 12.6 million shares of our common stock at an IPO price of $28.00 per share. The Company received net proceeds from the IPO of approximately $325.7 million after deducting underwriting discounts, commissions and other offering costs of $28.5 million.

Previous wording

As we look to the remainder of 2024, we anticipate net sales growth to be driven by organic growth, in particular the conversion of high levels of backlog of our existing products, and the impact from strategic acquisitions. Backlog primarily consists of firm orders for products that have not yet shipped. Additionally, continued inflationary pressures and supply chain disruptions may lead to higher material and labor costs. These pressures and disruptions have not had a material effect on our results of operations or capital resources, and we do not expect them to materially affect our outlook or business goals. During 2024, we have continued and plan to continue our commitment to develop new products and services, further market penetration, and pursue an aggressive acquisition strategy while seeking to maintain our financial strength and flexibility.

Current wording

As we look to the remainder of 2024, we anticipate net sales growth to be driven by organic growth, in particular the conversion of high levels of backlog of our existing products, and the impact from strategic acquisitions. Backlog primarily consists of firm orders for products that have not yet shipped. Continued inflationary pressures and supply chain disruptions may lead to higher material and labor costs although these pressures and disruptions have not had a material effect on our year-to-date results of operations or capital resources, and we do not expect them to materially affect our outlook or business goals. During 2024, we have continued and plan to continue our commitment to develop new products and services, further market penetration, and pursue an aggressive acquisition strategy while seeking to maintain our financial strength and flexibility.

Previous wording

The following table sets forth, for the three months ended March 31, 2024 and 2023, certain operating data of the Company, including presentation of the amounts as a percentage of net sales (in thousands unless otherwise indicated):

Current wording

The following table sets forth, for the three months and six months ended June 30, 2024 and 2023, certain operating data of the Company, including presentation of the amounts as a percentage of net sales (in thousands unless otherwise indicated):

Previous wording

Net acquisition sales of $9.3 million for the three months ended March 31, 2024 is made up of DAC and CAV which were acquired on July 3, 2023 and September 1, 2023, respectively. This represents 12.6% of the increase in total net sales for the three months ended March 31, 2024 compared to the three months ended March 31, 2023.

Current wording

Net acquisition sales of $10.5 million for the three months ended June 30, 2024 is made up of DAC and CAV which were acquired on July 3, 2023 and September 1, 2023, respectively. This represents 14.1% of the increase in total net sales for the three months ended June 30, 2024 compared to the three months ended June 30, 2023.

Previous wording

Cost of sales for the three months ended March 31, 2024 increased $9.2 million or 24.1% to $47.4 million compared to $38.2 million for the three months ended March 31, 2023. Cost of sales and the related percentage of net sales for the three months ended March 31, 2024 and 2023 were as follows (in thousands except for percentages):

Current wording

Cost of sales for the three months ended June 30, 2024 increased $13.0 million, or 35.5%, to $49.5 million compared to $36.5 million for the three months ended June 30, 2023. Cost of sales and the related percentage of net sales for the three months ended June 30, 2024 and 2023 were as follows (in thousands except for percentages):

Previous wording

Cost of sales for the three months ended March 31, 2024 increased 0.1% as a percentage of net sales to 51.6% from 51.5% in the comparable period last year. This increase in cost of sales is primarily attributable to the impact of costs related to the consolidation of certain operations as well as the DAC and CAV acquisitions which were not included in the results for the three months ended March 31, 2023. These increases were partially offset by the effect of our fixed overhead costs supporting higher production and sales levels.

Current wording

Cost of sales for the three months ended June 30, 2024 increased 1.6% as a percentage of net sales to 51.0% from 49.4% in the comparable period last year. This increase in cost of sales is primarily attributable to the impact of increased defense sales which typically have higher costs as a percentage of sales and the dilutive effects of an acquisition which was not included in the results for the three months ended June 30, 2023. These increases were partially offset by the leveraging of our fixed overhead costs supporting higher production and sales levels.

Previous wording

Selling, general and administrative expenses increased by $4.1 million to $22.9 million, or 24.9% as a percentage of net sales, for the three months ended March 31, 2024 from $18.8 million, or 25.4% as a percentage of net sales, for the three months ended March 31, 2023. Selling, general and administrative expenses and the related percentage of net sales for the three months ended March 31, 2024 and 2023 were as follows (amounts in thousands except for percentages):

Current wording

Selling, general and administrative expenses increased by $7.8 million to $27.3 million, or 28.1% as a percentage of net sales, for the three months ended June 30, 2024 from $19.5 million, or 26.3% as a percentage of net sales, for the three months ended June 30, 2023. Selling, general and administrative expenses and the related percentage of net sales for the three months ended June 30, 2024 and 2023 were as follows (amounts in thousands except for percentages):

Previous wording

Selling, general and administrative expenses declined by 0.5% as a percentage of net sales for the three months ended March 31, 2024 when compared to the same period in 2023. This was primarily driven by increased sales volume and the leveraging of fixed costs, offset by the DAC and CAV acquisitions in 2023.

Current wording

Selling, general and administrative expenses increased by 1.8% as a percentage of net sales for the three months ended June 30, 2024 when compared to the same period in 2023. This was primarily driven by stock-based compensation expense, research and development costs, and infrastructure costs related to being a public company, partially offset by the leveraging of fixed costs.

Previous wording

Transaction expenses for the three months ended March 31, 2024 and 2023 were $0.2 million. Transaction costs can fluctuate depending on the size and number of acquisitions in each year.

Current wording

Transaction expenses for the three months ended June 30, 2024 and 2023 were $0.9 million and $0.4 million, respectively. Transaction costs can fluctuate depending on the size and number of acquisitions in each year.

Previous wording

Operating income for the three months ended March 31, 2024, was $21.4 million, or 23.3% as a percentage of net sales, compared to $17.1 million, or 23.0% as a percentage of net sales for the three months ended March 31, 2023. The increase in operating income is due to the factors discussed above.

Current wording

Operating income for the three months ended June 30, 2024, was $22.2 million, or 22.9% as a percentage of net sales, compared to $17.6 million, or 23.8% as a percentage of net sales for the three months ended June 30, 2023. The increase in operating income is due to the factors discussed above.

Previous wording

Net income for the three months ended March 31, 2024 was $2.2 million, or 2.4% as a percentage of net sales, compared to the net loss for the three months ended March 31, 2023 of $7.5 million, or 10.1% as a percentage of net sales. The improvement in results is primarily due to the valuation allowance recognized in the year ago period in addition to the factors discussed above.

Current wording

Net income for the three months ended June 30, 2024 was $7.6 million, or 7.9% as a percentage of net sales, compared to net income for the three months ended June 30, 2023 of $0.6 million, or 0.8% as a percentage of net sales. The improvement in results is primarily due to the factors discussed above.

Previous wording

Net organic sales represent net sales from our existing businesses for comparable periods and exclude net sales from acquisitions. We include net sales from new acquisitions in net organic sales from the 13th-month after the acquisition on a comparative basis with the prior period. Net acquisition sales for the three months ended March 31, 2024 represent net sales from acquisitions that were completed in 2023 for which there are no comparable net sales during the prior year. We believe this measure provides an understanding of underlying sales trends as it provides net sales comparisons on a consistent basis. We do not believe our net sales are subject to significant seasonal variations. See Note 3, Acquisitions, of the Notes to Condensed Consolidated Financial Statements for further information on the Company’s acquisition activities.

Current wording

Net organic sales represent net sales from our existing businesses for comparable periods and exclude net sales from acquisitions. We include net sales from new acquisitions in net organic sales from the 13th-month after the acquisition on a comparative basis with the prior period. Net acquisition sales for the six months ended June 30, 2024 represent net sales from acquisitions that were completed in 2023 for which there are no comparable net sales during the prior year. We believe this measure provides an understanding of underlying sales trends as it provides net sales comparisons on a consistent basis. We do not believe our net sales are subject to significant seasonal variations. See Note 3, Acquisitions, of the Notes to Condensed Consolidated Financial Statements for further information on the Company’s acquisition activities.

Previous wording

Net organic sales for the three months ended March 31, 2024 increased $8.3 million, or 11.1%, to $82.5 million as compared to $74.2 million for the three months ended March 31, 2023. The increase in net organic sales was primarily related to increases in OEM total commercial sales ($6.0 million, an increase of 27.9%), aftermarket total commercial sales ($1.0 million, an increase of 3.3%) and defense sales ($1.2 million, an increase of 7.9%). The increase in OEM total commercial sales was driven primarily by increases in aircraft production across a significant portion of the platforms we supply, including general aviation, wide-body and narrow-body aircraft, as an improving supply chain has allowed us to deliver parts that were previously held because our customers were experiencing bottlenecks in other areas of their supply chains. The increase in aftermarket total commercial sales was primarily due to the continuing recovery in commercial air travel demand, partially offset by destocking at a handful of our distributors and end customers. The increase in defense sales was primarily driven by increased market share due to new product launches.

Current wording

Net organic sales for the six months ended June 30, 2024 increased $20.8 million, or 14.1%, to $169.0 million compared to $148.2 million for the six months ended June 30, 2023. The increase in net organic sales was primarily related to increases in defense sales ($8.6 million, an increase of 30.2%), OEM total commercial sales ($8.2 million, an increase of 17.9%) and aftermarket total commercial sales ($6.4 million, an increase of 11.4%). The increase in defense sales was primarily driven by increased market share due to new product launches. The increase in OEM total commercial sales was driven by increases in aircraft production for general aviation, wide-body and narrow-body aircraft, as an improving supply chain has allowed us to deliver parts that were previously held because our customers were experiencing bottlenecks in other areas of their supply chains. The increase in aftermarket total commercial sales was primarily due to the continuing recovery in commercial air travel demand, partially offset by destocking at a handful of our distributors and end customers.

Previous wording

The income tax provision for the three months ended March 31, 2024 decreased $7.8 million to $1.4 million compared to $9.2 million for the three months ended March 31, 2023. The decrease was a result of establishment of a valuation allowance against the Company’s deferred tax asset for its disallowed interest carryforward during the three months ended March 31, 2023.

Current wording

The effective income tax rate for the six months ended June 30, 2024 was 26.9% compared to 354.2% for the six months ended June 30, 2023. The decrease in the effective tax rate was primarily due to the establishment of a valuation allowance against the Company's deferred tax asset for its disallowed interest carryforward during the first quarter of 2023.

Previous wording

Our principal historical liquidity requirements have been for acquisitions, capital expenditures, servicing indebtedness and working capital needs. We fund our investing activities primarily from cash provided by our operating and financing activities. As of March 31, 2024, we had availability of $47 million of a Delayed Draw Term Loans Commitment (as defined below) and a $20 million revolving line of credit. Based on our current outlook, we believe that net cash provided by operating activities and available borrowings under our Credit Agreement will be sufficient to fund our cash requirements for at least the next twelve months. As we continue to expand our business, including by any acquisitions we may make, we may in the future require additional working capital for increased costs. See “Credit Agreement” (below) for additional detail regarding our financing activities.

Current wording

Our principal historical liquidity requirements have been for acquisitions, capital expenditures, servicing indebtedness and working capital needs. We fund our investing activities primarily from cash provided by our operating and financing activities. As of June 30, 2024, we had availability of $100 million of a Delayed Draw Term Loans Commitment (as defined below) and a $50 million revolving line of credit. Based on our current outlook, we believe that net cash provided by operating activities and available borrowings under our Credit Agreement will be sufficient to fund our cash requirements for at least the next twelve months. As we continue to expand our business, including by any acquisitions we may make, we may in the future require additional working capital for increased costs. See “Credit Agreement” (below) for additional detail regarding our financing activities.

Previous wording

Net cash used in investing activities in the three months ended March 31, 2024 and 2023 was due to capital expenditures of $2.4 million and $1.9 million, respectively.

Current wording

Net cash used in investing activities in the six months ended June 30, 2024 and 2023 of $3.8 million and $4.7 million, respectively, was primarily due to capital expenditures of $4.5 million and $4.7 million, respectively.

Previous wording

Our long-term debt consists of borrowings under our Credit Agreement, originally entered into on October 2, 2017.

Current wording

The Company’s long-term debt consists primarily of borrowings under its Credit Agreement.

Previous wording

On May 10, 2024, the Credit Agreement was amended and restated to extend the maturity date to May 10, 2030 and reduce the applicable margin by between 2.0 and 2.5 percentage points based on our leverage ratio. At our election, interest on loans will accrue at the SOFR rate plus the applicable margin of 4.75% or at the base rate plus the applicable margin of 3.75% as long as we maintain a leverage ratio of less than 5.5 to 1. We also increased the existing availability under our Delayed Draw Term Commitment to $100 million, which terminates if not drawn upon by May 10, 2026. In addition, the existing revolving line of credit under the Credit Agreement was replaced with a new revolving credit commitment of $50 million. The unused portion of the revolving line of credit carries a commitment fee of 0.375%. Loans outstanding under the revolving line of credit, if any, mature on May 10, 2029.

Current wording

On May 10, 2024, the Credit Agreement was amended to extend the maturity date to May 10, 2030 from April 2, 2026 and reduce the applicable margin by between 2.0 and 2.5 percentage points based on the Company’s leverage ratio. At the Company’s election, interest on loans will accrue at the SOFR rate plus the applicable margin of 4.75% or at the base rate plus the applicable margin of 3.75% as long as the Company maintains a leverage ratio of less than 5.5 to 1. The Company also increased the existing availability under its Delayed Draw Term Commitment to $100 million, which terminates if not drawn upon by May 10, 2026. In addition, the existing revolving line of credit under the Credit Agreement was replaced with a new revolving credit commitment of $50 million. The unused portion of the revolving line of credit carries a commitment fee of 0.375%. Loans outstanding under the revolving line of credit, if any, mature on May 10, 2029. The Company capitalized approximately $0.9 million in debt issuance costs associated with the amendment during the three and six months ended June 30, 2024.

Previous wording

We have future obligations under various contracts relating to debt and interest payments, finance and operating leases and our post-retirement benefit plan. During the three months ended March 31, 2024, there were no material changes to these obligations as described in our December 31, 2023 annual financial statements reported in the Company’s Form S-1 filed with the Securities and Exchange Commission.

Current wording

We have future obligations under various contracts relating to debt and interest payments, finance and operating leases and our post-retirement benefit plan. During the six months ended June 30, 2024, there were no material changes to these obligations as described in our December 31, 2023 annual financial statements reported in the Company’s Form S-1 filed with the Securities and Exchange Commission.

Previous wording

A complete and comprehensive discussion of our most critical accounting policies that require management to make judgments about matters that are inherently uncertain was included in Management’s Discussion and Analysis of Financial Condition and Results of Operations– Critical Accounting Estimates for the year ended December 31, 2023 which was filed with Amendment No. 2 to Form S-1 filed on April 23, 2024. Refer to Note 2, Basis of Presentation, of the notes to the condensed consolidated financial statements included herein for updates to disclosures of accounting standards recently adopted or required to be adopted in the future.

Current wording

A complete and comprehensive discussion of our most critical accounting policies that require management to make judgments about matters that are inherently uncertain was included in Management’s Discussion and Analysis of Financial Condition and Results of Operations– Critical Accounting Estimates for the year ended December 31, 2023 which was filed with Amendment No. 2 to Form S-1 on April 23, 2024. Refer to Note 2, Basis of Presentation, of the notes to the condensed consolidated financial statements included herein for updates to disclosures of accounting standards recently adopted or required to be adopted in the future.

Previous wording

The following table sets forth a reconciliation of net income (loss) to EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin for the three months ended March 31, 2024 and 2023 (in thousands unless otherwise indicated):

Current wording

The following table sets forth a reconciliation of net income (loss) to EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin for the three and six months ended June 30, 2024 and 2023 (in thousands unless otherwise indicated):

Previous wording

Other income for the three months ended March 31, 2023, of $48 thousand was related to a grant from the U.S. Department of Transportation under the Aviation Manufacturing Jobs Protection Program (AMJP). There was no other income during the three months ended March 31, 2024.

Current wording

Represents the reduction in the estimated contingent purchase price for the CAV acquisition in 2024 and a grant from the U.S. Department of Transportation under the Aviation Manufacturing Jobs Protection Program in 2023..

Previous wording

Represents the non-cash compensation expense recognized by the Company for our restricted equity unit awards.

Current wording

Represents the non-cash compensation expense recognized by the Company for equity awards.
Rearranged current paragraphs (6)

Current report — wording carried from elsewhere

Net organic sales represent net sales from our existing businesses for comparable periods and exclude net sales from acquisitions. We include net sales from new acquisitions in net organic sales from the 13th-month after the acquisition on a comparative basis with the prior period. Net acquisition sales for the three months and six months ended June 30, 2024 represent net sales from acquisitions that were completed in 2023 for which there are no comparable net sales during the prior year. We believe this measure provides an understanding of underlying sales trends as it provides net sales comparisons on a consistent basis. We do not believe our net sales are subject to significant seasonal variations. See Note 3, Acquisitions, of the Notes to Condensed Consolidated Financial Statements for further information on the Company’s acquisition activities.

Current report — wording carried from elsewhere

Net organic sales for the three months ended June 30, 2024 increased $12.6 million, or 17.0%, to $86.6 million as compared to $74.0 million for the three months ended June 30, 2023. The increase in net organic sales was primarily related to increases in defense sales ($7.4 million, an increase of 56.1%), aftermarket total commercial sales ($5.4 million, an increase of 20.4%) and OEM total commercial sales ($2.2 million, an increase of 9.0%). The increase in defense sales was primarily driven by increased market share due to new product launches. The increase in aftermarket total commercial sales was primarily due to the continuing recovery in commercial air travel demand. The increase in OEM total commercial sales was driven by increases in aircraft production for general aviation, wide-body and narrow-body aircraft, as an improving supply chain has allowed us to deliver parts that were previously held because our customers were experiencing bottlenecks in other areas of their supply chains.

Current report — wording carried from elsewhere

Net acquisition sales of $19.8 million for the six months ended June 30, 2024, is made up of DAC and CAV which were acquired on July 30, 2023 and September 1, 2023, respectively. This represents 13.4% of the increase in total net sales for the six months ended June 30, 2024 compared to the six months ended June 30, 2023.

Current report — wording carried from elsewhere

Gross Profit and Cost of Sales

Current report — wording carried from elsewhere

Cost of sales for the six months ended June 30, 2024 increased 0.9% as a percentage of net sales to 51.3% from 50.4% in the comparable period last year. This increase in cost of sales is primarily attributable to the impact of increased defense sales, which typically have higher costs as a percentage of sales and the dilutive effects of an acquisition which was not included in the results for the six months ended June 30, 2023. These increases were partially offset by the leveraging of our fixed overhead costs supporting higher production and sales levels.

Current report — wording carried from elsewhere

Transaction expenses for the six months ended June 30, 2024 and 2023 were $1.1 million and $0.6 million, respectively. Transaction costs can fluctuate depending on the size and number of acquisitions in each year.
Rearranged previous paragraphs (1)

Previous report — wording carried elsewhere

Represents a grant from the U.S. Department of Transportation under the AMJP.